Status:

WITHDRAWN

Early Detection of Alcoholic Liver Disease

Lead Sponsor:

University of Pittsburgh

Conditions:

Alcoholic Liver Disease

Alcoholic Fibrosis of Liver

Eligibility:

All Genders

21+ years

Brief Summary

This is an observational study to identify the prevalence of advanced liver fibrosis among patients with excessive alcohol intake using a non-invasive method (FibroScan®) and to characterize the main ...

Detailed Description

Background: The Global Status Report on Alcohol and Health 2014 from the World Health Organization indicates that alcohol abuse accounts for 50% of cirrhosis worldwide. Therefore, alcoholic liver dis...

Eligibility Criteria

Inclusion

  • Patients diagnosed with an alcohol use disorder (AUD) identification test (AUDIT) with a total score of 8 or more or patients with a score lower than 8 in the AUDIT test but for whom there is a high suspicion of current or recent (within one year) AUD based on medical history or self-reported history of excessive alcohol use, stigmata of alcohol use on physical exam, liver chemistry abnormalities, and/or alcohol-induced organ involvement other than decompensated liver disease.
  • Patients who admit having a persistent alcohol intake of more than 40 g/daily for women and 60 g/daily for men.
  • Patients with abnormal AST, ALT, GGT and/or bilirubin.
  • 21 years of age or older.
  • Signed informed consent.

Exclusion

  • Patients with a history of liver disease or decompensated advanced liver disease (i.e: jaundice episodes, ascites, hepatic encephalopathy, variceal bleeding, hepatorenal syndrome) or known hepatocellular carcinoma.
  • Patients with severe extrahepatic disease or terminal illness.
  • Patients who are pregnant or breast-feeding. However, pre-menopausal women capable of bearing children will be allowed to participate in the study provided they have a reliable method of birth control and have a negative pregnancy test prior to inclusion.

Key Trial Info

Start Date :

April 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 3 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04070508

Start Date

April 1 2023

End Date

November 3 2025

Last Update

March 17 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Early Detection of Alcoholic Liver Disease | DecenTrialz